AMGN Jul 2024 215.000 put
| Previous close | 0.9500 |
| Open | 0.8800 |
| Bid | 0.0500 |
| Ask | 2.2700 |
| Strike | 215.00 |
| Expiry date | 2024-07-19 |
| Day's range | 0.8800 - 0.8800 |
| Contract range | N/A |
| Volume | |
| Open interest | 42 |
- Yahoo Finance Video
Amgen surges over confidence in early obesity drug results
Shares of Amgen (AMGN) are jumping Friday morning after the company showed confidence in early results from a GLP-1 weight-loss drug that is in development to treat obesity. The pharmaceutical giant beat first-quarter revenue estimates while reporting a loss of $113 million. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins The Morning Brief to break down the latest developments from Amgen and its outlook on use cases for the drug in question, MariTide. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Nicholas Jacobino
BloombergAmgen Soars as CEO Touts Experimental Obesity Drug Progress
(Bloomberg) -- Amgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by early results from a study of the company’s experimental obesity drug, MariTide. Most Read from BloombergSaudi Arabia Steps Up Arrests Of Those Attacking Israel OnlineApple Rallies Most in 18 Months on Upbeat Forecast, BuybackTurkey Confirms All Trade Halt With Israel Over War in GazaHuawei Secretly Backs US Research, Awarding Millions in PrizesTrump Auditions VP Picks Before Wealthy Dono
- Reuters
US STOCKS-Wall St set to open sharply higher on soft jobs data
Wall Street's main indexes were set to open higher on Friday after a softer-than-expected jobs report revived hopes of the Federal Reserve cutting interest rates this year, while gains in Apple and Amgen on upbeat corporate updates added support. The Labor Department report showed U.S. nonfarm payrolls increased by 175,000 jobs in April, compared with expectations for an increase of 243,000, according to economists polled by Reuters.
